Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Letter to the Editor

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs

Saori Takamura, Yuichi Teraki, Eri Katayama, Takumi Kawaguchi, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Sumiko Nagoshi, Takekuni Nakama, Takuji Torimura

Clin Mol Hepatol. 2022;28(2):269-272. Published online February 15, 2022

DOI: https://doi.org/10.3350/cmh.2022.0040

View: 2548 Download: 240 Citations: 4

Review

MAFLD enhances clinical practice for liver disease in the Asia-Pacific region

Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura

Clin Mol Hepatol. 2022;28(2):150-163. Published online November 10, 2021

DOI: https://doi.org/10.3350/cmh.2021.0310

View: 4041 Download: 289 Citations: 20

Editorial

Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma

Sooyeon Oh, Jooho Lee

Clin Mol Hepatol. 2020;26(4):476-479. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0192

View: 3356 Download: 131 Citations: 9

Original Article

Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals

Yvelise Ferro, Ilaria Carè, Elisa Mazza, Francesco Provenzano, Carmela Colica, Carlo Torti, Stefano Romeo, Arturo Pujia, Tiziana Montalcini

Clin Mol Hepatol. 2017;23(3):249-259. Published online July 28, 2017

DOI: https://doi.org/10.3350/cmh.2017.0019

View: 10369 Download: 145 Citations: 16

Viewed By 4639	Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Viewed By 3552	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 2596	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 2270	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2211	Recent updates on the management of autoimmune hepatitis

Cited By 89	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 40	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 36	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 34	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 34	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Nutritional and Metabolic liver disease